Authors:
Krueger, JG
Walters, IB
Miyazawa, M
Gilleaudeau, P
Hakimi, J
Light, S
Sherr, A
Gottlieb, AB
Citation: Jg. Krueger et al., Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor)on T cells by administration of humanized anti-Tac antibody to patients with psoriasis, J AM ACAD D, 43(3), 2000, pp. 448-458
Authors:
Przepiorka, D
Kernan, NA
Ippoliti, C
Papadopoulos, EB
Giralt, S
Khouri, I
Lu, JG
Gajewski, J
Durett, A
Cleary, K
Champlin, R
Andersson, BS
Light, S
Citation: D. Przepiorka et al., Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease, BLOOD, 95(1), 2000, pp. 83-89
Citation: S. Light, Rejecting the logic of confinement: Care relationships and the mentally disabled under Tort law, YALE LAW J, 109(2), 1999, pp. 381-416
Authors:
Lehky, TJ
Levin, MC
Kubota, R
Bamford, RN
Flerlage, AN
Soldan, SS
Leist, TP
Xavier, A
White, JD
Brown, M
Fleisher, TA
Top, LE
Light, S
McFarland, HF
Waldmann, TA
Jacobson, S
Citation: Tj. Lehky et al., Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac, ANN NEUROL, 44(6), 1998, pp. 942-947